E
Eledon Pharmaceuticals, Inc.
ELDN · NASDAQ · Healthcare · 273M
Price · close
$3.45
-1.99% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
3.5×
Enterprise value / EBITDAEV/EBITDA
-5.7×
Free cash flow yieldFCF yield
-22.1%
Return on equityROE
-56.3%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.5×
Interest coverage
—
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.